Press releases
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
Key statistics
On Thursday, Omeros Corp (0KBU:LSE) closed at 2.99, 201.50% above the 52 week low of 0.99 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.99 |
Average volume | 1.74k |
---|---|
Shares outstanding | 57.94m |
Free float | 55.41m |
P/E (TTM) | -- |
Market cap | 177.30m USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 20 minutes, as of Apr 25 2024 15:44 BST.
More ▼